Litcius/Paper detail

Efficacy of a third SARS-CoV-2 mRNA vaccine dose among hematopoietic cell transplantation, CAR T cell, and BiTE recipients

Muhammad Bilal Abid, Micah Rubin, Nathan A. Ledeboer, Anikó Szabó, Walter Longo, Meera Mohan, Nirav N. Shah, Timothy S. Fenske, Sameem Abedin, Lyndsey Runaas, Anita D’Souza, Saurabh Chhabra, Binod Dhakal, Mehdi Hamadani

2022Cancer Cell52 citationsDOIOpen Access PDF

Topics & Concepts

Hematopoietic cellVirologyHematopoietic stem cell transplantationTransplantationSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)ImmunologyCoronavirus disease 2019 (COVID-19)2019-20 coronavirus outbreakCellMedicineHaematopoiesisBiologyStem cellInfectious disease (medical specialty)GeneticsDiseasePathologyInternal medicineOutbreakSARS-CoV-2 and COVID-19 ResearchCAR-T cell therapy researchImmunotherapy and Immune Responses
Efficacy of a third SARS-CoV-2 mRNA vaccine dose among hematopoietic cell transplantation, CAR T cell, and BiTE recipients | Litcius